Kilpeläinen, A.; Saubi, N.; Guitart, N.; Olvera, A.; Hanke, T.; Brander, C.; Joseph, J.
Recombinant BCG Expressing HTI Prime and Recombinant ChAdOx1 Boost Is Safe and Elicits HIV-1-Specific T-Cell Responses in BALB/c Mice. Vaccines 2019, 7, 78.
https://doi.org/10.3390/vaccines7030078
AMA Style
Kilpeläinen A, Saubi N, Guitart N, Olvera A, Hanke T, Brander C, Joseph J.
Recombinant BCG Expressing HTI Prime and Recombinant ChAdOx1 Boost Is Safe and Elicits HIV-1-Specific T-Cell Responses in BALB/c Mice. Vaccines. 2019; 7(3):78.
https://doi.org/10.3390/vaccines7030078
Chicago/Turabian Style
Kilpeläinen, Athina, Narcís Saubi, Núria Guitart, Alex Olvera, Tomáš Hanke, Christian Brander, and Joan Joseph.
2019. "Recombinant BCG Expressing HTI Prime and Recombinant ChAdOx1 Boost Is Safe and Elicits HIV-1-Specific T-Cell Responses in BALB/c Mice" Vaccines 7, no. 3: 78.
https://doi.org/10.3390/vaccines7030078
APA Style
Kilpeläinen, A., Saubi, N., Guitart, N., Olvera, A., Hanke, T., Brander, C., & Joseph, J.
(2019). Recombinant BCG Expressing HTI Prime and Recombinant ChAdOx1 Boost Is Safe and Elicits HIV-1-Specific T-Cell Responses in BALB/c Mice. Vaccines, 7(3), 78.
https://doi.org/10.3390/vaccines7030078